Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Augmedix Inc Science Novo Nordisk A/S
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Breaking news Biotech and Pharmaceuticals Business News
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Eli Lilly and Co Roche Holding AG Biotech and Pharmaceuticals
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Business News Business Biotechnology
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Business News Novo Nordisk A/S Breaking News: Business
From CNBC.com News
Jim Cramer supports megacaps for the long term, even as Wall Street continues to sell
Tags NVIDIA Corp Stock markets Meta Platforms Inc
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
Tags Artificial intelligence Eli Lilly and Co Taiwan Semiconductor Manufacturing Co Ltd
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
Tags Microsoft Corp Meta Platforms Inc NVIDIA Corp
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Pharmaceuticals Markets Roche Holding AG
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Science Novo Nordisk A/S Merck & Co Inc
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Health care industry Health & Science Novo Nordisk A/S
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Eli Lilly and Co Pharmaceuticals US: News
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Business Novo Nordisk A/S Business News
From CNBC.com News
Jim Cramer reviews 8 companies that could top $1 trillion in market cap
Tags Alphabet Inc Business U/S/ Markets
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Biotechnology Business Novo Nordisk A/S
From CNBC.com News
Companies besides tech can reach megacap status, Jim Cramer says
Tags Markets Apple Inc stocks
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags ETF Edge Finance Investing
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Gilead Sciences Inc Eli Lilly and Co CVS Health Corp
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Nasdaq Inc Paramount Global NVIDIA Corp
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Electric vehicles Tesla Inc Asia Markets
From CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
Tags Eli Lilly and Co US: News Pharmaceuticals
From CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
Tags Eli Lilly and Co Investing Exchange/traded funds
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Oracle Corp Altimmune Inc Viking Therapeutics Inc
From CNBC.com News
Jim Cramer's top picks for pet-centric stocks
Tags THE JM SMUCKDRN Business Chewy Inc
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Pharmaceuticals US: News Asia News
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Health care industry Health & Science Companies
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Tags Health & Science Companies Health care industry
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Europe News Pharmaceuticals Markets
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Social issues Healthy Returns Eli Lilly and Co
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Health care industry Companies Health & Science
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.